Kwality Pharmaceuticals migrates from BSE-SME

To Main Board of BSE

Kwality Pharmaceuticals has received approval from BSE Limited vide letter reference no. LO/Migration/SC/MIG-TP/86/2022-23 dated June 10, 2022, wherein BSE has approved the Company's application with respect to migration of equity shares of the company from BSE SME platform to BSE Main Board Platform w.e.f 13 June 2022 and the Company will be categorized under the list of 'B' Group Category.

Powered by Capital Market - Live News